RAFFA WEALTH MANAGEMENT, LLC’s Revolution Medicines RVMD Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.62K	Buy	+46	New	+$6.72K	﹤0.01%	462

Other funds holding RVMD

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

APM

a16z Perennial Management Menlo Park, California $1.24B AUM 7.36% 1-Year Est. Return

WPC

Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's RVMD Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC opened a new position in Revolution Medicines (RVMD) in Q2 2026: 46 shares worth $8.62K. The stake represents ﹤0.01% of the portfolio and ranks #462 among its holdings.

154 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC held 46 shares of Revolution Medicines worth $8.62K as of Q2 2026.
Revolution Medicines was a new RAFFA WEALTH MANAGEMENT, LLC position in Q2 2026.
Revolution Medicines made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #462 holding.
154 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.